Profile data is unavailable for this security.
About the company
BRAIN Biotech AG, formerly known as BRAIN Biotechnology Research and Information Network AG is a Germany-based industrial biotechnology company develops and brings to market biological ingredients for Nutrition & Health, SkinCare and Industrial BioSolutions. Research & Development activities focus on bioactive natural compounds, tailored enzymes and high-performance microorganisms.
- Revenue in EUR (TTM)55.23m
- Net income in EUR-8.40m
- Incorporated2000
- Employees311.00
- LocationBRAIN Biotech AGDarmstaedter Strasse 34-36ZWINGENBERG 64673GermanyDEU
- Phone+49 625193310
- Fax+49 6 251933111
- Websitehttps://www.brain-biotech.de/
More ▼
Mergers & acquisitions
| Acquired company | BNNX.N:GER since announced | Transaction value |
|---|---|---|
| Biocatalysts Ltd | -46.25% | -- |
Data delayed at least 15 minutes, as of May 06 2024 16:36 BST.
16.23%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Universal-Investment-Gesellschaft mbH (Invt Mgmt)as of 16 Nov 2022 | 698.53k | 3.20% |
| Wydler Asset Management AGas of 31 Mar 2024 | 568.99k | 2.60% |
| Apo Asset Management GmbHas of 30 Sep 2023 | 492.37k | 2.25% |
| Deka Investment GmbHas of 31 Dec 2023 | 404.89k | 1.85% |
| Joh. Berenberg, Gossler & Co. KG (Investment Management)as of 31 Oct 2023 | 341.90k | 1.57% |
| FPM Frankfurt Performance Management AGas of 29 Feb 2024 | 332.00k | 1.52% |
| MEAG MUNICH ERGO Kapitalanlagegesellschaft mbHas of 29 Sep 2023 | 329.39k | 1.51% |
| Deutsche Bank AG (Private Banking Germany)as of 29 Feb 2024 | 222.00k | 1.02% |
| UBS Asset Management (Deutschland) GmbHas of 29 Sep 2023 | 82.97k | 0.38% |
| Generali Investments LLCas of 30 Jun 2023 | 73.01k | 0.33% |
More ▼
Data from 30 Jun 2023 - 31 Mar 2024Source: FactSet Research Systems Inc.
